Abstract: In our pilot study, we analyzed medications administered at Vanderbilt University Medical Center to determine optimal targets for intravenous (IV) to oral (PO) conversion. Using clinical decision support (CDS), we targeted non-critically ill inpatient adults on IV medications for IV-to-PO conversion. Our findings show potential for IV-to-PO conversion to reduce cost and improve safety. We present a framework for selecting medications, implementing CDS, and measuring outcomes.

Describe the new knowledge and additional skills the participant will gain after attending your presentation.: Attendees will learn how to plan and implement decision support for intravenous (IV) to oral (PO) conversion of inpatient medications at their institutions. Topics include medication selection, clinical decision support (CDS) implementation, and cost savings analysis.

Authors:

Robert Turer (Presenter)
Vanderbilt University Medical Center

Claude Pirtle, Vanderbilt University Medical Center
David Mulherin, Vanderbilt University Medical Center
Shane Stenner, Vanderbilt University Medical Center
Scott Nelson, Vanderbilt University Medical Center
Allison McCoy, Vanderbilt University Medical Center
Mhd Alrifai, Vanderbilt University Medical Center
Christoph Lehmann, Vanderbilt University Medical Center